Immuneering uses advanced proprietary techniques to identify hidden signals and biological insights across an array of genetic, genomic and proteomic data that can direct research for improved discovery,
The trials will investigate BGB-283 in patients with B-RAF mutations in a range of tumors where no other effective targeted therapies are currently available in China. In addition,
The partnership builds on a broad existing relationship between the two firms and supports AstraZeneca’s strategic approach in these therapeutic areas using new RNA-targeted treatments as well as
Spritam uses the company’s ZipDose Technology platform which in turn uses three-dimensional printing (3DP) to produce a porous formulation that rapidly disintegrates with a sip of liquid. Earlier,
CL-H1T, which contains fast-dissolving promethazine and sumatriptan, is being developed to treat migraine headache pain and migraine-induced nausea and vomiting (MINV). Charleston Laboratories chief scientific officer Bernard Schachtel
In November 2011, Synthon filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) for a once daily 20mg/ml formulation of glatiramer acetate,
The acquisition will give Shire access to the global rights of Foresight’s FST-100, a topical ophthalmic drops combining 0.6% povidone iodine (PVP-I) and 0.1% dexamethasone. FST-100 is a
EDO-S101 combines the DNA damaging effect of bendamustine with the pan-histone deacetylase inhibitor (HDACi) vorinostat, with the aim of increasing the efficacy of the alkylator through the HDACi-mediated
PI causes an individual to have a deficient or absent immune system due to either a lack of necessary antibodies or a failure of these antibodies to function
Under the company’s contract with HHS-BARDA, the trial has been funded in whole or in part with Federal funds from the Office of the Assistant Secretary for Preparedness
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.